service
[용어속성] Term
Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions
Research Paper
[키워드] adjusted relative risk
Affect
affected
anti-hypertensive drug
anti-resorptive drugs
association
Barcelona
Bisphosphonates
calcium
Cohort
Comorbidities
condition
conditions
conducted
coronavirus disease 19
COVID-19
COVID-19 incidence
COVID-19 patients
cross-sectional
cumulative
Denosumab
determine
diuretics
Elderly patient
estimate
Evidence
global pandemic
had no
incidence
incidence of COVID-19
influence
investigated
non-steroidal anti-inflammatory drug
oral
Osteoarthritis
Osteoporosis
pandemic
Pathologies
Patient
Poisson regression model
service
Spain
Support
the SARS-CoV-2
treated
Treatment
Vitamin D
with COVID-19
zoledronate
[DOI] 10.18632/aging.104117 PMC 바로가기 [Article Type] Research Paper
[DOI] 10.18632/aging.104117 PMC 바로가기 [Article Type] Research Paper
Information about COVID-19 among Selected Population of Eastern Nepal: A Descriptive Cross-sectional Study
Original Article
Published on
Journal: JNMA: Journal of the Nepal Medical Association [Category] COVID-19, MERS, SARS,
Journal: JNMA: Journal of the Nepal Medical Association [Category] COVID-19, MERS, SARS,
[키워드] eastern Nepal
information
calculated
clearance
collected
conducted
confidence
coronavirus
Course
COVID-19
cross-sectional
ethical review board
Frequency
Health
help
information
interval
knowledge
media
Nepal
Participants
Point
Population
preventive measure
preventive measures
professionals
proportion
questionnaire
Rapid
selected
service
Spread
spread of COVID-19
Statistical Package
Strong
the disease
was done
was used
website
WHO
[DOI] 10.31729/jnma.5096 PMC 바로가기 [Article Type] Original Article
[DOI] 10.31729/jnma.5096 PMC 바로가기 [Article Type] Original Article
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 1:1
24 hour
Ability
absence
accompany
activity
Administered
administration
Admission
adverse events
Affect
age
alkaline phosphatase
allergy
ALT
alternative hypothesis
ambient
Analysis
ANC
Anti-inflammatory
anticipated
antipyretics
antivirals
Arm
ARMS
assumed
AST
Baltimore
baseline
benefit
blinded
block
block randomization
Blood
breastfeeding women
Bronchoalveolar lavage
calculated
Care
Cellulose
center
Chest
chest X-ray
childbearing potential
clinical
clinical condition
Clinical course
clinical impact
Clinical improvement
Clinical outcome
clinical status
clinical trial
collected
competing
Compliance
concealed
Concentration
Concomitant
conditions
conducted
congestive heart failure
Contraception
Control
control arm
Conventional
Corticosteroids
COVID-19
COVID-19 disease
COVID-19 infection
COVID-19 pandemic
criteria
criterion
Critical
CT scan
current
Day
Declaration of Helsinki
decrease
defined
detect
direct bilirubin
disease
disorder
dissemination
dose
double-blind
drug
Drug administration
drug-drug interaction
drugs
Duration
ECMO
Efficacy
Efficacy and safety
element
eligible
endosomal pH
Enrollment
ethnic group
evaluate
Evidence
exclusion
expected
exploratory endpoint
extracorporeal membrane oxygenation
Face mask
FDA
Fisher
Good
group
handling
harmonization
hematologic
histocompatibility complex
Hospitalization
Hospitalized
hospitalized patient
Hydroxychloroquine
Hypothesis
ICU
IL-6 levels
Imatinib
immunomodulatory
immunomodulatory drugs
IND
information
Informed consent
inhibitory activity
intensive care
intensive care unit
intention to treat
interfere
International Conference
invasive
Invasive mechanical ventilation
investigational agent
investigator
ITT
Laboratory
Last
limit
limitation
liver
Local
lysosomal sequestration
magnitude
matching placebo
mechanical ventilation
men and women
MHC
mononuclear cell
Mortality
nasal
nasopharyngeal
Nasopharyngeal swab
neutrophil count
New
new oxygen use
non-invasive ventilation
non-rebreather mask
not blinded
null hypothesis
number
objective
off-label
off-label use
Oropharyngeal
outcome
outcomes
oxygen
Oxygenation
P450
packaged
PaO
participant
Participants
Patient
patients
patients with ARDS
patients with COVID-19
PBMCs
performed
Pharmacist
Pharmacy
phase 3 study
Placebo
placebo-controlled
Pneumonia
positive COVID-19
Practice
primary analysis
primary endpoint
principal
progression
proportion
protocol
Psychiatric
Radiographic
random number generator
randomised controlled trial
randomization
Randomized
Randomized controlled trial
receive
receiving
recruitment
Regulatory
renal dysfunction
renal replacement therapy
replication of SARS-CoV-2
required
requiring supplemental oxygen
Respiratory illness
respiratory tract
risk
RT-PCR
Safety
Sample size
sarilumab
SARS-CoV
SARS-CoV-2
secondary endpoint
Seizure
Serious Adverse Events
service
severe disease
severity
significance level
Site
Society
stability
Standard of care
status
stratified
study drug
study enrollment
study outcomes
Study protocol
subject
submitted
supplemental oxygen
Support
Suspension
symptomatic
Tablet
temperature
Test
the patient
the primary endpoint
time
TKI
TKI-induced attenuation of vascular leak
TKI-induced prevention and treatment lung inflammation
Tocilizumab
transcriptomics
Treatment
treatment allocation
treatment arm
treatments for COVID-19
Trial
two-sided
tyrosine kinase inhibitor
uncontrolled
university
unstable angina
vasopressors
ventilator
ventilator free days
viral ABL-1 signalling
website
with COVID-19
[DOI] 10.1186/s13063-020-04819-9 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04819-9 PMC 바로가기 [Article Type] Letter
Patient Perceptions about Professional Dental Services during the COVID-19 Pandemic
COVID-19
[키워드] Access to care
Adults
age
agency
Care
clinical practice guidelines
community dentistry
condition
COVID-19
cross-sectional
demographics
dental
dental health survey
dental public health
event
help
high risk
hygiene
include
Infection
information
Last
over
pandemic
pandemic progresses
Patient
patients
Perceived risk
Perception
populations
positive
professional
provide
Psychosocial factors
public health
receiving
reported
risk
routine care
Safe
service
study participant
survey
susceptibility
susceptible
variable
[DOI] 10.1177/2380084420969116 PMC 바로가기 [Article Type] COVID-19
[DOI] 10.1177/2380084420969116 PMC 바로가기 [Article Type] COVID-19
Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System
Research
[키워드] addition
Adjusted analysis
Adjusting
Admission
age
alcohol
antibody tests
black
Black patient
BMI
body mass index
calculated
Cancer
Characteristics
classification
cohort study
Comorbidities
Comorbidity
coronavirus disease
covariates
COVID-19
COVID-19 hospitalization
COVID-19 infections
death
defined
Department
determine
diagnosed with COVID-19
died
disparity
examined
explained
exposure
Factor
finding
group
health condition
high-risk population
higher risk
Hospitalization
hospitalizations
Hospitalized
Human
ICU
ICU admission
Importance
increased risk
individual
intensive care
Kidney disease
Male sex
measure
Mortality
nasopharynx
Ninth
obesity
objective
Odds ratio
Older age
outcome
outcomes
participant
Patient
PCR
performed
Point
polymerase chain
positive
positive COVID-19
Racial
Randomly
reason
Relevance
Result
retrospective cohort study
revision
risk factor
selected
service
setting
Sex
smoking
Sociodemographic
Sociodemographic characteristics
Sociodemographic factor
statistically significant
Support
System
targeted intervention
tested
treated
type 2 diabete
type 2 diabetes
University of Michigan
white
White patient
White patients
with COVID-19
[DOI] 10.1001/jamanetworkopen.2020.25197 PMC 바로가기 [Article Type] Research
[DOI] 10.1001/jamanetworkopen.2020.25197 PMC 바로가기 [Article Type] Research
Outcomes of Orthopaedic Trauma Services at a UK Major Trauma Centre During a National Lockdown and Pandemic: The Need for Continuing the Provision of Services
Orthopedics
[키워드] Admission
anaesthesia
anatomical
case-control study
changed
collected
Complication
complications
COVID
COVID-19
criteria
disease
Emergency surgery
fractures
Hip fractures
incidence
include
increase
Injury
Intervention
less
level 1
lockdown
lockdowns
Major
Mortality
National
no decrease
operative
operative procedure
Orthopaedic trauma
orthopaedics surgery
outcome
pandemic
Pandemics
Patient
performed
PPE
provided
public health
reduced
remained
Result
retrospective
service
significantly
tested
the patient
trauma
trauma centers
Volume
was performed
[DOI] 10.7759/cureus.11056 PMC 바로가기 [Article Type] Orthopedics
[DOI] 10.7759/cureus.11056 PMC 바로가기 [Article Type] Orthopedics
SARS-CoV-2 Testing and Changes in Primary Care Services in a Multistate Network of Community Health Centers During the COVID-19 Pandemic
Article
[키워드] Cancer
center
change
Community
COVID-19
Health
health center
network
offered
primary care
SARS-CoV-2
SARS-CoV-2 testing
service
Testing
[DOI] 10.1001/jama.2020.15891 PMC 바로가기 [Article Type] Article
[DOI] 10.1001/jama.2020.15891 PMC 바로가기 [Article Type] Article
Impact of COVID-19 on Obesity Management Services in the United Kingdom (The COMS-UK study)
Brief Communication
[키워드] anticipated
Bariatric surgery
clinician
clinics
complex
conducted
coronavirus disease-2019
COVID-19
COVID-19 pandemic
global healthcare
Impact
involved
majority
management
MOST
obesity
pandemic
Patient
physician
professional
reduced
service
United Kingdom
[DOI] 10.1007/s11695-020-05005-1 PMC 바로가기 [Article Type] Brief Communication
[DOI] 10.1007/s11695-020-05005-1 PMC 바로가기 [Article Type] Brief Communication
Mapping Evidence of Pharmacy Services for COVID-19 in China
Pharmacology
[키워드] Analysis
article
articles
case sery
changes in
China
Chinese
collected data
Consensus
COVID-19
COVID-19 outbreak
COVID-19 pandemic
COVID-19 patient
criteria
database
disease
emergency supply
evidence of
guideline development
identify
implementation
Infection
Infrastructure
Intervention
limit
literature review
majority
mapping
Medicine
objective
pandemic
Patient
Pharmacist
Pharmacy
pharmacy service
Prevent
restrict
Result
searched
service
service model innovation
spread of COVID-19
Symptom
treat
Treatment
treatment regimen
treatment regimens
website
[DOI] 10.3389/fphar.2020.555753 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2020.555753 PMC 바로가기 [Article Type] Pharmacology